| scholarly article | Q13442814 |
| P356 | DOI | 10.1053/J.GASTRO.2016.03.005 |
| P698 | PubMed publication ID | 26980624 |
| P2093 | author name string | Zobair Younossi | |
| Linda Henry | |||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | metabolic dysfunction–associated steatotic liver disease | Q1546498 |
| fatty liver disease | Q6058862 | ||
| liver disease | Q929737 | ||
| P304 | page(s) | 1778-1785 | |
| P577 | publication date | 2016-03-12 | |
| P1433 | published in | Gastroenterology | Q4039279 |
| P1476 | title | Contribution of Alcoholic and Nonalcoholic Fatty Liver Disease to the Burden of Liver-Related Morbidity and Mortality | |
| P478 | volume | 150 |
| Q64274684 | A Novel Discovery: Holistic Efficacy at the Special Organ Level of Pungent Flavored Compounds from Pungent Traditional Chinese Medicine |
| Q50035208 | Anarchy in the UPR: A Ca2+-insensitive PKC inhibits SERCA activity to promote ER stress |
| Q33882332 | Animal Models of Alcoholic Liver Disease: Pathogenesis and Clinical Relevance |
| Q37236384 | Assessment of health utilities and quality of life in patients with non-alcoholic fatty liver disease |
| Q40367115 | Assessment of treatment response in non-alcoholic steatohepatitis using advanced magnetic resonance imaging. |
| Q47559184 | Association between obstructive sleep apnea and non-alcoholic fatty liver disease: a systematic review and meta-analysis |
| Q89893716 | Association of Bone Metabolism with Fatty Liver Disease in the Elderly in Japan: A Community-based Study |
| Q59813695 | Bidirectional Association between Nonalcoholic Fatty Liver Disease and Gallstone Disease: A Cohort Study |
| Q50936974 | ChREBP refines the hepatic response to fructose to protect the liver from injury. |
| Q89645694 | Changes in the Global Burden of Chronic Liver Diseases From 2012 to 2017: The Growing Impact of Nonalcoholic Fatty Liver Disease |
| Q59356897 | Changing Trends in Etiology-Based Annual Mortality From Chronic Liver Disease, From 2007 Through 2016 |
| Q36291704 | Characterisation of liver fat in the UK Biobank cohort. |
| Q40054265 | Cohort Contributions to Race- and Gender-Specific Trends in the Incidence of Hepatocellular Carcinoma in the USA. |
| Q64988810 | Commonalities and Distinctions Between Alcoholic and Nonalcoholic Fatty Liver Disease. |
| Q92330882 | Comprehensive evaluation of effects and safety of statin on the progression of liver cirrhosis: a systematic review and meta-analysis |
| Q60935690 | Consumption of decaffeinated coffee protects against the development of early non-alcoholic steatohepatitis: Role of intestinal barrier function |
| Q54760091 | Controlled Attenuation Parameter as a Noninvasive Method to Detect and Quantify Hepatic Steatosis in Chronic Liver Disease: What Is the Clinical Relevance? |
| Q47569225 | Cross-Cultural Adaptation and Psychometric Properties of the AUDIT and CAGE Questionnaires in Tanzanian Swahili for a Traumatic Brain Injury Population |
| Q91856917 | Deregulation of Hepatic Mek1/2⁻Erk1/2 Signaling Module in Iron Overload Conditions |
| Q64227387 | Diagnostic accuracy of red blood cell distribution width to platelet ratio for predicting staging liver fibrosis in chronic liver disease patients: A systematic review and meta-analysis |
| Q90998913 | Early detection and staging of chronic liver diseases with a protein MRI contrast agent |
| Q48371300 | Editorial: there is trouble ahead, but just how much? The troubling reality of America's excesses and NAFLD. |
| Q57113468 | Effects of isomaltulose on insulin resistance and metabolites in patients with non‑alcoholic fatty liver disease: A metabolomic analysis |
| Q93161544 | Fatty liver index as a predictor of increased risk of cardiometabolic disease: finding from the Kuopio Ischaemic Heart Disease Risk Factor Study Cohort |
| Q39290975 | Gut-liver axis and sterile signals in the development of alcoholic liver disease |
| Q41602786 | Hepatocyte-Specific Deletion of Mouse Lamin A/C Leads to Male-Selective Steatohepatitis |
| Q98293262 | Hospitalization costs and risk of mortality in adults with nonalcoholic steatohepatitis: Analysis of a French national hospital database |
| Q64239602 | Immunoregulatory Effect of Koumine on Nonalcoholic Fatty Liver Disease Rats |
| Q40468739 | Improvement in liver histology due to lifestyle modification is independently associated with improved kidney function in patients with non-alcoholic steatohepatitis. |
| Q92454677 | Letter to the Editor: Suggestions for Rational Management of Nonalcoholic Fatty Liver Disease |
| Q33866766 | MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals. |
| Q53704720 | Managing the Burden of Non-NASH NAFLD. |
| Q58611546 | Mitochondria as a therapeutic target for common pathologies |
| Q36221271 | Neglected features of lifestyle: Their relevance in non-alcoholic fatty liver disease |
| Q99712219 | Non-alcoholic Fatty Liver Disease and Alcohol-Related Liver Disease: Two Intertwined Entities |
| Q53833366 | Non-alcoholic steatofibrosis (NASF) can independently predict mortality in patients with non-alcoholic fatty liver disease (NAFLD). |
| Q90416246 | Nonalcoholic Fatty Liver Disease |
| Q96111283 | Nonalcoholic Fatty Liver Disease and Alcoholic Liver Disease are Major Drivers of Liver Mortality in the United States |
| Q47779219 | Nonalcoholic Fatty Liver Disease as a Nexus of Metabolic and Hepatic Diseases |
| Q92322372 | Nonalcoholic fatty liver disease and mortality from all causes, cardiovascular disease, and cancer: a meta-analysis |
| Q92504940 | Pathogenesis of Insulin Resistance and Atherogenic Dyslipidemia in Nonalcoholic Fatty Liver Disease |
| Q90709883 | Patient-Reported Outcomes and the Economic Effects of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: The Value Proposition |
| Q58727386 | Prevalence of hepatic steatosis as assessed by controlled attenuation parameter (CAP) in subjects with metabolic risk factors in primary care. A population-based study |
| Q54948913 | Protein phosphatase 1 regulatory subunit 3B gene variation protects against hepatic fat accumulation and fibrosis in individuals at high risk of nonalcoholic fatty liver disease. |
| Q60948076 | RIPK3-Mediated Necroptosis and Neutrophil Infiltration Are Associated with Poor Prognosis in Patients with Alcoholic Cirrhosis |
| Q64059534 | Rare Pathogenic Variants Predispose to Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease |
| Q94475883 | Shorter leucocyte telomere length as a potential biomarker for nonalcoholic fatty liver disease-related advanced fibrosis in T2DM patients |
| Q91728777 | Target genes associated with lipid and glucose metabolism in non-alcoholic fatty liver disease |
| Q52571014 | The Association of Gut Microbiota with Nonalcoholic Steatohepatitis in Thais. |
| Q38676257 | The Diagnosis and Management of Nonalcoholic Fatty Liver Disease: Practice Guidance from the American Association for the Study of Liver Diseases. |
| Q52630916 | The High Burden of Alcoholic Cirrhosis in Privately Insured Persons in the United States. |
| Q52314588 | The Stomach as an Endocrine Organ: Expression of Key Modulatory Genes and Their Contribution to Obesity and Non-alcoholic Fatty Liver Disease (NAFLD). |
| Q39471203 | The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe |
| Q99609197 | The role of acylated ghrelin and unacylated ghrelin in the blood and hypothalamus and their interaction with nonalcoholic fatty liver disease |
| Q42367659 | Therapeutic opportunities for alcoholic steatohepatitis and nonalcoholic steatohepatitis: exploiting similarities and differences in pathogenesis |
| Q89462214 | Transient elastography for alcoholic liver disease: a step forward |
| Q96343545 | Vibration-Guided Transient Elastography: A Novel Fibroscan Examination with Improved Guidance for Liver Stiffness Measurement |
| Q51761242 | p53 as a Dichotomous Regulator of Liver Disease: The Dose Makes the Medicine. |
Search more.